Medicines for Europe warns strongly against energy rationing for medicines production

20 July 2022

The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!

1 July 2022

The off-patent medicines industry is a vital part of the solution for healthcare resilience

30 June 2022

Smart reform of EU pharma and IP legislation key to boosting access to essential medicines

28 June 2022

EPSCO (Health) Council – Open letter from Medicines for Europe Executive Committee to European Health Ministers and responsible European Commissioners on inflation impacting the supply of essential medicines

9 June 2022

Central & Eastern European patients have inequitable access to medicines for life-threatening conditions

25 April 2022

Repurposing: a golden opportunity for patient centric health investment in Europe

6 April 2022

Report shows the future of meeting unmet medical needs relies […]

EU pharmaceutical legislation must support a competitive off-patent industry to deliver equitable access to medicines

20 December 2021

Strong support for new measures to protect patient access to medicines in Northern Ireland

20 December 2021

Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health

15 December 2021